The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replicationCaroline Q. Sacramento, Thiago Moreno L. Souza, Natasha Rocha et al.|bioRxiv (Cold Spring Harbor Laboratory)|2016Cited by 25